The Global Health Primer connects the capable innovators that drive research and development for new drugs, vaccines, and diagnostics to the neglected diseases where innovation is desperately needed. It provides a source of compiled and synthesized information for 25 neglected diseases of the developing world and the drugs, vaccines, and diagnostics in use or in development for the management of these diseases. The Global Health Primer: 

• Tracks and analyzes progress in global health research and development
• Provides an evidence base to support decision making, policy change, and action
• Brings new innovators to the table to address the most pressing medical needs of the poor

Since the re-launch of the Global Health Primer in March 2011, BVGH has successfully conducted quarterly updates of the report content and significantly expanded the content. In 2012, the Global Health Primer Scientific Advisory Board (SAB) was formed to review all contents of the Primer, and to ensure the data are scientifically accurate and reliable. BVGH also published an overview of the current pipeline in the Global Health Primer: 2012 Snapshot.

To learn more, please select one of the choices:

Watch a short demo of the Global Health Primer here:

If you missed the Global Health Primer webinar on March 8, 2011, you can watch it here.

Pipelines and products are continuously updated throughout the year. To learn how you can get involved in neglected disease drug, vaccine or diagnostic research and development, or to provide updates, changes, or corrections to the Global Health Primer website, please view our FAQs or contact us at globalhealthprimer@bvgh.org.

Last updated: August 15, 2012